Skip to content
Join free
Back

Nutrition & DietWomen with PCOS

PCOS and blood sugar: what the guideline actually recommends

Movement and food are recommended for the metabolic side of PCOS. The research under that advice is still very thin, and no one diet or workout wins.

Checked against the sources ยท Updated 17 Nov 2026

In short

  • The 2023 international PCOS guideline recommends lifestyle help for metabolic health in all women with PCOS. It does not crown one diet or one workout, and it says routine insulin blood tests are not useful.
  • The guideline's lifestyle recommendation is strong, and the certainty of the evidence underneath it is very low. Metformin is a considered option for some adults, on the same thin evidence, and it is a prescription decision.

PCOS and blood sugar: what the guideline actually recommends

The measuring tape is already on the desk when you sit down. The chart already has the name. What you came to ask is narrower than the whole of PCOS: the blood sugar, the waist, the lipids, the part people call metabolic and then bury under a meal plan from a chat. You want to know what actually helps that part.

The 2023 international guideline has a first sentence, and it is more modest than the meal plans. Help with food and movement should be offered for metabolic health to all women with PCOS, and the research under that sentence is very thin. No one diet wins. No one workout wins. A routine insulin blood test is not the tool they want. Metformin is a medicine some adults may discuss with a clinician, on that same thin evidence, not a step you take in the kitchen.

What the lifestyle recommendation actually says

Teede and colleagues published the recommendations from the international guideline in the Journal of Clinical Endocrinology and Metabolism in 2023. The lifestyle recommendation says an intervention should be offered to all women with PCOS, to improve metabolic health, including fat carried around the middle and the lipid profile. It can be exercise alone, or diet combined with exercise and behavioral strategies.

The panel still wants clinicians to offer it, and it says in the same breath that the research underneath is very thin, so there is little confidence in how large the effect is. A firm suggestion sitting on soft research is not the same thing as a settled fact, and the guideline does not pretend otherwise.

A separate line from the same document says healthy eating, physical activity, or both should be recommended to support general health, quality of life, body composition, and weight, including keeping weight stable and avoiding further gain. That is a wider aim than "fix the glucose." It includes the week you are already having.

No winning plate, and no winning workout

Two limits keep this from becoming a meal plan with your name on it.

The guideline says there is not enough evidence to call any one type or intensity of exercise better than another for body size, metabolic, hormonal, reproductive, or psychological outcomes. It says the same about diet: no one way of composing the plate has been shown to be better than the others for those outcomes. If someone hands you the one true PCOS plate, the guideline did not crown it.

It also says a healthy lifestyle can help even when weight does not change. Goals are supposed to be built with the woman, around what she actually values, not handed down. Clinicians are told to watch for weight stigma when they talk about lifestyle. The tape on the desk is a measurement. It is not a character note.

In people who are not living with a higher weight, including adolescents, the focus the guideline names is a healthy pattern and preventing further gain, not a loss target. That sentence matters if the plan you were offered assumed weight loss was the only respectable goal.

The insulin test it does not want in routine care

Insulin resistance is part of the biology the guideline describes. The same document says the insulin assays clinics usually run are of limited use, and should not be part of routine care. A fasting insulin drawn to see whether you are resistant is not the test that decides this. Glucose, lipids, waist, and the rest of metabolic care are the practical picture. You can ask for those without asking for a number the guideline has already set aside.

Metformin is a medicine, not a step between meals

The guideline says metformin alone should be considered in adults with PCOS and a body mass index of 25 or higher, for body size and for metabolic outcomes, including glucose and lipids. That line sits on the same thin research. Under a body mass index of 25, metformin may be considered, and the guideline says the evidence there is limited. "Should be considered" and "may" are different strengths. Neither one is a kitchen instruction.

No dose is repeated here, on purpose. Starting or stopping metformin is a clinician's decision. The guideline notes gut side effects, and that note is not a list of what to take or what to skip. If glucose, lipids, or waist size are the worry, two questions stay separate: whether lifestyle support is the plan, and whether metformin is a medicine to discuss. One does not cancel the other.

What this will not promise

It will not say PCOS is caused by sugar, or that a low-sugar week will change a cycle. Cycle medicines and fertility treatments are outside this article. Inositol is not reviewed here. A Philippine count of how common PCOS is is not quoted, and the absence of a local number is not a reason to borrow one.

What you can leave with is smaller, and it is enough. Food and movement are recommended for the metabolic side. The research under them is thin. No single plan won. A routine insulin level is not the tool the guideline wants. Metformin, for some adults, is a prescription conversation on that same thin evidence.

When an article is the wrong tool

Do not use an article to give yourself the label of PCOS, and do not use it to stop a prescribed medicine. Diagnosis sits with a clinician who can see the whole picture, including cycles, androgens, and ultrasound when those are needed. Medicines sit there too. Bring the question you actually have, the glucose or the waist or the lipids, and the fact that you want the plan built with you rather than handed to you. That request is already in the guideline. The tape can stay on the desk. The decision stays with that clinician.

---

Sources

  • Teede HJ, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism. 2023. https://doi.org/10.1210/clinem/dgad463

General guidance, not medical advice or a diagnosis. Talk with your doctor about your own health.

How strong is the evidence?

Some evidence

What the research says: The guideline says there are benefits from a healthy lifestyle even without weight loss, and that goals should be set with the woman, not handed down. It tells clinicians to watch weight stigma. Metformin for adults under a body mass index of 25 is a weaker 'may,' with limited evidence. No dose is copied here.

What it doesn't say: This does not say PCOS is caused by sugar, and it does not say a low-sugar week will regularize cycles. Cycle medicines and fertility treatments are outside this article. Inositol is not reviewed here. A Philippine PCOS prevalence figure was not opened.

Teede HJ, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism. 2023.

How we rate: the Flamel Method

Try this

  • Pick a way of eating you can repeat and a kind of movement you will actually do. The guideline found no winning diet and no winning workout for the metabolic outcomes it graded.
  • If glucose, lipids, or waist size are the worry, ask whether lifestyle support is the plan and, separately, whether metformin is on the table. A fasting insulin drawn to check resistance is not what the guideline recommends in routine care.

That counts.

See a doctor if You are using this page to self-label PCOS, or to stop a prescribed medicine. Diagnosis and medicines sit with a clinician who can see the whole picture, including cycles, androgens, and ultrasound when those are needed.

Get delightful living tips directly in your email

Join free

Keep reading

Sources

  1. Teede HJ, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism. 2023.

Last reviewed by Flamel Staff on 17 Nov 2026

Flamel is not medical advice and does not diagnose. If you have symptoms or readings in the red zone, see a doctor.